Topical Cream with 0.5% Active

OTHER2 trials

Sponsors

Amazentis SA

Conditions

ErythemaSkin AgingSkin InflammationSun Damaged Skin

Unknown Phase

Evaluation of the Anti-aging Efficacy of a Novel Skin Health Product

CompletedNCT05300984

Amazentis SASkin Aging

Start: 2022-03-15End: 2022-05-16Updated: 2023-04-06

Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema

CompletedNCT05300542

Amazentis SAErythema, Skin Inflammation, Sun Damaged Skin

Start: 2022-03-17End: 2022-04-13Updated: 2023-04-06